Cite
Kurth I, Yamaguchi N, Andreu-Agullo C, et al. Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Sci Adv. 2021;7(41):eabi7511doi: 10.1126/sciadv.abi7511.
Kurth, I., Yamaguchi, N., Andreu-Agullo, C., Tian, H. S., Sridhar, S., Takeda, S., Gonsalves, F. C., Loo, J. M., Barlas, A., Manova-Todorova, K., Busby, R., Bendell, J. C., Strauss, J., Fakih, M., McRee, A. J., Hendifar, A. E., Rosen, L. S., Cercek, A., Wasserman, R., Szarek, M., Spector, S. L., Raza, S., Tavazoie, M. F., & Tavazoie, S. F. (2021). Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Science advances, 7(41), eabi7511. https://doi.org/10.1126/sciadv.abi7511
Kurth, Isabel, et al. "Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels." Science advances vol. 7,41 (2021): eabi7511. doi: https://doi.org/10.1126/sciadv.abi7511
Kurth I, Yamaguchi N, Andreu-Agullo C, Tian HS, Sridhar S, Takeda S, Gonsalves FC, Loo JM, Barlas A, Manova-Todorova K, Busby R, Bendell JC, Strauss J, Fakih M, McRee AJ, Hendifar AE, Rosen LS, Cercek A, Wasserman R, Szarek M, Spector SL, Raza S, Tavazoie MF, Tavazoie SF. Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Sci Adv. 2021 Oct 08;7(41):eabi7511. doi: 10.1126/sciadv.abi7511. Epub 2021 Oct 06. PMID: 34613776; PMCID: PMC8494442.
Copy
Download .nbib